The DOI matches its Crossref record; 2 of the 2 references it cites were found in a registry or an index.
One-Year Association of Drug Possession Law Change With Fatal Drug Overdose in Oregon and Washington
Open accessAbstract
Importance: Two states modified laws to remove or substantially reduce criminal penalties for any drug possession. The hypothesis was that removing criminal penalties for drug possession may reduce fatal drug overdoses due to reduced incarceration and increased calls for help at the scene of an overdose. Objective: To evaluate whether decriminalization of drug possession in Oregon and Washington was associated with changes in either direction in fatal drug overdose rates. Design, Setting, and Participants: This cohort study used a synthetic control method approach to examine whether there were changes in drug possession laws and fatal drug overdose rates in Oregon and Washington in the postpolicy period (February 1, 2021, to March 31, 2022, in Oregon and March 1, 2021, to March 31, 2022, in Washington). A counterfactual comparison group (synthetic controls) was created for Oregon and Washington, using 48 states and the District of Columbia, that did not implement similar policies during the study period (January 1, 2018, to March 31, 2022). For 2018-2021, final multiple cause-of-death data from the National Vital Statistics System (NVSS) were used. For 2022, provisional NVSS data were used. Drug overdose deaths were identified using International Statistical Classification of Diseases and Related Health Problems, 10th Revision underlying cause-of-death codes X40-X44, X60-X64, X85, and Y10-Y14. Exposures: In Oregon, Measure 110 went into effect on February 1, 2021. In Washington, the Washington Supreme Court decision in State v Blake occurred on February 25, 2021. Main Outcome: Monthly fatal drug overdose rates. Results: Following the implementation of Measure 110, absolute monthly rate differences between Oregon and its synthetic control were not statistically significant (probability = 0.26). The average rate difference post Measure 110 was 0.268 fatal drug overdoses per 100 000 state population. Following the implementation of the policy change in Washington, the absolute monthly rate differences between Washington and synthetic Washington were not statistically significant (probability = 0.06). The average rate difference post Blake was 0.112 fatal drug overdoses per 100 000 state population. Conclusions and Relevance: This study found no evidence of an association between legal changes that removed or substantially reduced criminal penalties for drug possession in Oregon and Washington and fatal drug overdose rates. Additional research could examine potential other outcomes as well as longer-term associations with fatal drug overdose overall and across racial and ethnic groups.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Koester, S., Mueller, S. R., Raville, L., Langegger, S., & Binswanger, I. A. (2017) · International Journal of Drug Policy · doi:10.1016/j.drugpo.2017.06.008 · Cited by 165
Smiley-McDonald, H. M., Attaway, P. R., Wenger, L. D., Greenwell, K., Lambdin, B. H., & Kral, A. H. (2023) · International Journal of Drug Policy · doi:10.1016/j.drugpo.2023.104100 · Cited by 51
Flagged first, then by citations
Research works printed but not linked: 19
- Davis, 2022, Legality of drug checking equipment in the United States: a systematic legal analysis., Drug Alcohol Depend, 234, 10.1016/j.drugalcdep.2022.109425 · DOI
- Townsend, 2022, Use of an inverted synthetic control method to estimate effects of recent drug overdose Good Samaritan laws, overall and by Black/White race/ethnicity., Am J Epidemiol, 191, 1783, 10.1093/aje/kwac122 · DOI
- Smart, 2021, Systematic review of the emerging literature on the effectiveness of naloxone access laws in the United States., Addiction, 116, 6, 10.1111/add.v116.1 · DOI
- Lee, 2021, Systematic evaluation of state policy interventions targeting the US opioid epidemic, 2007-2018., JAMA Netw Open, 4, 10.1001/jamanetworkopen.2020.36687 · DOI
- Ivsins, 2020, Tackling the overdose crisis: the role of safe supply., Int J Drug Policy, 80, 10.1016/j.drugpo.2020.102769 · DOI
- Bonn, 2020, Addressing the syndemic of HIV, hepatitis C, overdose, and COVID-19 among people who use drugs: the potential roles for decriminalization and safe supply., J Stud Alcohol Drugs, 81, 556, 10.15288/jsad.2020.81.556 · DOI
- Latimore, 2017, “Caught with a body” yet protected by law? calling 911 for opioid overdose in the context of the Good Samaritan Law., Int J Drug Policy, 50, 82, 10.1016/j.drugpo.2017.09.010 · DOI
- McLean, 2018, Good Samaritans vs. predatory peddlers: problematizing the war on overdose in the United States., J Crime Justice, 41, 1, 10.1080/0735648X.2016.1215932 · DOI
- Netherland, 2022, Principles and metrics for evaluating Oregon’s innovative drug decriminalization measure., J Urban Health, 99, 328, 10.1007/s11524-022-00606-w · DOI
- von Elm, 2007, Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies., BMJ, 335, 806, 10.1136/bmj.39335.541782.AD · DOI · Paper page
- Abadie, 2010, Synthetic control methods for comparative case studies: estimating the effect of California’s tobacco control program., J Am Stat Assoc, 105, 493, 10.1198/jasa.2009.ap08746 · DOI · Paper page
- Galiani, 2017, The Synth_Runner package: utilities to automate synthetic control estimation using Synth., Stata J, 17, 834, 10.1177/1536867X1801700404 · DOI
- Linden, 2018, Combining synthetic controls and interrupted time series analysis to improve causal inference in program evaluation., J Eval Clin Pract, 24, 447, 10.1111/jep.2018.24.issue-2 · DOI
- Beletsky, 2015, Fatal re-entry: legal and programmatic opportunities to curb opioid overdose among individuals newly released from incarceration., Northeastern University Law J, 7, 149
- O’Connor, 2022, Overdose and substance-related mortality after release from prison in Washington State: 2014-2019., Drug Alcohol Depend, 241, 10.1016/j.drugalcdep.2022.109655 · DOI · Paper page
- Krawczyk, 2020, Opioid overdose death following criminal justice involvement: linking statewide corrections and hospital databases to detect individuals at highest risk., Drug Alcohol Depend, 213, 10.1016/j.drugalcdep.2020.107997 · DOI
- Abadie, 2015, Comparative politics and the synthetic control method., Am J Pol Sci, 59, 495, 10.1111/ajps.12116 · DOI
- Spencer, 2022, Drug Overdose Deaths in the United States, 2001–2021. NCHS Data Brief, No. 457, 10.15620/cdc:122556 · DOI
- Ahmad, 2021, Provisional Drug Overdose Death Counts
Cited by
Sorted by citations
Drug Decriminalization, Fentanyl, and Fatal Overdoses in Oregon
Zoorob, M. J., Park, J. N., Kral, A. H., Lambdin, B. H., & del Pozo, B. (2024) · JAMA Network Open · doi:10.1001/jamanetworkopen.2024.31612 · Cited by 52
The decriminalization of illicit drugs in British Columbia: a national evaluation protocol.
Russell, C., Ali, F., Imtiaz, S., Butler, A., Greer, A., Rehm, J., the Decriminalization Evaluation Research Group, Bardwell, G., Bonn, M., Boyd, J., et al. (2024) · BMC Public Health · doi:10.1186/s12889-024-20336-9 · Cited by 19
Safer Opioid Supply, Subsequent Drug Decriminalization, and Opioid Overdoses
Nguyen, H. V., Mital, S., Bugden, S., & McGinty, E. E. (2025) · JAMA Health Forum · doi:10.1001/jamahealthforum.2025.0101 · Cited by 10
Decriminalization of drug possession in British Columbia and hospitalizations for opioid poisoning
Rehm, J., Abdul, S. A., Ali, F., Russell, C., Crépault, J.-F., Elton-Marshall, T., Le Foll, B., Kinniburgh, B., Palis, H., & Imtiaz, S. (2025) · Public Health · doi:10.1016/j.puhe.2025.105915 · Cited by 3
Metadata
- Authors
- Joshi, S., Rivera, B. D., Cerdá, M., Guy, G. P., Strahan, A., Wheelock, H., & Davis, C. S.
- Affiliations
- New York University (US)
- Centers for Disease Control and Prevention (US)
- Outside In, Portland, Oregon
- Corresponding author
- Joshi, Spruha
- ORCID
- Venue
- JAMA Psychiatry
- Publisher
- American Medical Association (AMA)
- Published
- 2023-12-01
- Volume
- 80
- Issue
- 12
- Pages
- 1277
- ISSN
- 2168-622X (ISSN-L)
- PMC
- PMC10535015
- OpenAlex
- W4387077169
- Cited by
- 22
- References
- 2
- Citations by year
- 2026: 1 · 2025: 9 · 2024: 11 · 2023: 1
- FWCI
- 5.63
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- JAMA Psychiatry (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Opioid Use Disorder Treatment
- Health Sciences › Medicine › Epidemiology › Substance Abuse Treatment and Outcomes
- Social Sciences › Law › Criminal Law and Policy
- Keywords
- drug overdose deaths, drug policy, Oregon, Washington, incarceration, harm reduction, synthetic control method, heroin, fentanyl, methamphetamine, cocaine, cannabis, synthetic cannabinoids, stimulants
- MeSH terms
- Analgesics, Opioid, Humans, Legislation, Drug, Oregon, Washington, Cohort Studies, Drug Overdose
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review